Pallas Capital Advisors LLC Takes $3.83 Million Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Pallas Capital Advisors LLC bought a new position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 58,258 shares of the company’s stock, valued at approximately $3,829,000. Pallas Capital Advisors LLC owned 0.58% of iShares U.S. Pharmaceuticals ETF as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. US Bancorp DE boosted its stake in iShares U.S. Pharmaceuticals ETF by 137.0% during the 3rd quarter. US Bancorp DE now owns 384 shares of the company’s stock valued at $27,000 after purchasing an additional 222 shares during the period. Assetmark Inc. boosted its position in shares of iShares U.S. Pharmaceuticals ETF by 100.0% in the third quarter. Assetmark Inc. now owns 432 shares of the company’s stock valued at $31,000 after acquiring an additional 216 shares during the period. Allworth Financial LP grew its stake in shares of iShares U.S. Pharmaceuticals ETF by 9.4% in the third quarter. Allworth Financial LP now owns 1,853 shares of the company’s stock worth $131,000 after acquiring an additional 159 shares during the last quarter. EP Wealth Advisors LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF in the third quarter worth $157,000. Finally, Farther Finance Advisors LLC increased its position in iShares U.S. Pharmaceuticals ETF by 97.1% during the third quarter. Farther Finance Advisors LLC now owns 2,482 shares of the company’s stock worth $175,000 after acquiring an additional 1,223 shares during the period.

iShares U.S. Pharmaceuticals ETF Stock Up 2.1 %

iShares U.S. Pharmaceuticals ETF stock traded up $1.39 during mid-day trading on Monday, reaching $67.27. The company had a trading volume of 104,136 shares, compared to its average volume of 75,262. The firm has a market cap of $679.43 million, a price-to-earnings ratio of 6.49 and a beta of 0.58. The company has a 50 day moving average of $67.47 and a 200-day moving average of $68.99. iShares U.S. Pharmaceuticals ETF has a 52 week low of $62.31 and a 52 week high of $72.94.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.